Magnetospheric Multiscale Mission

NASA Selects Four Small Explorer Mission Concept Studies

Retrieved on: 
Friday, September 29, 2023
Aurora, Constellation, National Center for Atmospheric Research, Heliophysics, Mechanics, Field line, Atmospheric Research, University, Borsa Italiana, Magnetosphere, Katharine Reeves, NASA Headquarters, MMS, Goddard Space Flight Center, Research, Multimedia, Explorers Program, Dartmouth College, Cross, Science, CINEMA, Plasma, CubeSat, Deep Time History, Magnetospheric Multiscale Mission, Astronaut, NASA, Extreme, Coronal, Coronal mass ejection, Knowledge, EUV, Smithsonian Astrophysical Observatory, Communications satellite, Management

WASHINGTON, Sept. 29, 2023 /PRNewswire/ -- NASA has selected four small explorer missions to conduct concept studies.

Key Points: 
  • WASHINGTON, Sept. 29, 2023 /PRNewswire/ -- NASA has selected four small explorer missions to conduct concept studies.
  • "These four mission concept studies were selected because they address compelling science questions and could greatly impact the field of heliophysics," said Nicky Fox, the associate administrator for science at NASA Headquarters in Washington.
  • The principal investigator for the CINEMA mission concept study is Robyn Millan from Dartmouth College, in Hanover, New Hampshire.
  • "These mission concept study selections provide so much promise to ongoing heliophysics research," said Peg Luce, acting Heliophysics division director at NASA Headquarters.

Rocket Lab selected by Ball Aerospace to Power NASA’s GLIDE Spacecraft

Retrieved on: 
Thursday, June 9, 2022
Air, Technology, Satellite, Transport, Aerospace, Manufacturing, Neutron, Parker Solar Probe, SAP, Atmosphere, Rocket Lab, Magnetospheric Multiscale Mission, Electron, Spacecraft, Dynamics, National Oceanic and Atmospheric Administration, CEO, Carbon, Moon, MMS, NASA, Sun, SWFO-L1, Heliophysics Science Division, Ball Aerospace & Technologies, Lab, Communications satellite, Photon, Mars

Rocket Lab (Nasdaq: RKLB) (Rocket Lab or the Company), a leading launch and space systems company, has been selected by Ball Aerospace to manufacture the Solar Array Panel (SAP) to power NASAs Global Lyman-Alpha Imager of Dynamic Exosphere (GLIDE) mission spacecraft planned to launch in 2025.

Key Points: 
  • Rocket Lab (Nasdaq: RKLB) (Rocket Lab or the Company), a leading launch and space systems company, has been selected by Ball Aerospace to manufacture the Solar Array Panel (SAP) to power NASAs Global Lyman-Alpha Imager of Dynamic Exosphere (GLIDE) mission spacecraft planned to launch in 2025.
  • The GLIDE spacecraft will launch with another Rocket Lab-powered spacecraft, also built by Ball Aerospace, the National Oceanic and Atmospheric Administrations (NOAAs) Space Weather Follow On-Lagrange 1 (SWFO-L1).
  • Rocket Lab has become the go-to provider of space solar power and space systems products throughout the space industry, including for ambitious heliophysics missions like GLIDE, said Rocket Lab founder and CEO, Peter Beck.
  • I am grateful to our partners at Ball Aerospace for selecting Rocket Lab and excited to be working with them to support NASAs Heliophysics missions to deliver advanced science.

MMS Poised for an Innovative Future with Best Clinical Research Organization Award and Two Key Executive Appointments

Retrieved on: 
Wednesday, July 21, 2021
Technology, Biotechnology, Other Professional Services, Health, Consulting, Pharmaceutical, Professional services, Other Science, Research, Medical devices, General Health, Science, Data management, Clinical trials, Magnetospheric Multiscale Mission, MMS

This comes as the company was awarded Best Data-Focused Biotech CRO in the International Life Sciences Awards.

Key Points: 
  • This comes as the company was awarded Best Data-Focused Biotech CRO in the International Life Sciences Awards.
  • Hill and Gayari are long-time members of the executive leadership team at MMS, which has remained steadfast and unchanged for the past decade.
  • MMS has maintained strong, organic growth since its inception, and these most recent promotions reflect that.
  • In recent weeks, MMS surpassed a total of 800 colleagues across North America, Asia, Europe, and South Africa.

MMS Education Appoints Jodie Buenning to Executive Vice President

Retrieved on: 
Wednesday, November 13, 2019
Given names, Humans, Names, Geomagnetism, Magnetospheric Multiscale Mission, Jodie

PHILADELPHIA, Nov. 13, 2019 /PRNewswire/ -- MMS Education, a national marketing, communications, strategic consulting firm helping corporations and organizations make a positive impact in the education market, announces the appointment of Jodie Buenning to Executive Vice President.

Key Points: 
  • PHILADELPHIA, Nov. 13, 2019 /PRNewswire/ -- MMS Education, a national marketing, communications, strategic consulting firm helping corporations and organizations make a positive impact in the education market, announces the appointment of Jodie Buenning to Executive Vice President.
  • "We're thrilled to welcome Jodie to the MMS Education team.
  • Prior to joining MMS Education, Jodie served as vice president of marketing and communications for bulb Digital Portfolio, an education start-up.
  • She will join Suzanne Caimi Lynn , President of MMS Education, at the 2019 Corporate Citizenship Conference: Solve Together , being held in Washington, DC, on November 13 15.

MMS Holdings Announces Status as a Finalist for Best Contract Research Organization – Specialist Providers in Scrip Awards During 10th Annual Scientific Symposium

Retrieved on: 
Thursday, October 10, 2019
Other Professional Services, Pharmaceutical, Small business, Other Consumer, Professional services, Medical devices, Clinical trials, Science, Consumer, Research, Health, Articles, Pharmaceutical industry, Biotechnology, Clinical research, Contract research organization, Pharmaceuticals policy, Informa, Economy, Scrip, Magnetospheric Multiscale Mission, Life sciences

MMS Holdings (MMS) an award-winning, data-focused CRO announced its recognition as a finalist in the highly-esteemed, global Scrip Awards by Informa Pharma Intelligence as Best Contract Research Organization Specialist Providers at the 10th Annual MMS Scientific Symposium.

Key Points: 
  • MMS Holdings (MMS) an award-winning, data-focused CRO announced its recognition as a finalist in the highly-esteemed, global Scrip Awards by Informa Pharma Intelligence as Best Contract Research Organization Specialist Providers at the 10th Annual MMS Scientific Symposium.
  • The award announcement was made at the companys 10th annual Scientific Symposium, held on October 9-10, 2019, at MMS global headquarters in Canton, Michigan.
  • The Scrip Awards for Best Contract Research Organization acknowledge the critical role that CROs play in drug development.
  • MMS Holdings was chosen from a wide pool of entries and is listed alongside other top CROs in the category of Best Contract Research Organization Specialist Providers.

MMS Holdings and Sage IT Celebrate 10-Year Relationship with Deep Focus on Intelligent Automation and Bot Development

Retrieved on: 
Thursday, August 1, 2019
Other Science, Other Technology, Research, Pharmaceutical, Software, Consulting, Professional services, Data management, Science, Technology, Clinical trials, General Health, Health, Automation, Magnetospheric Multiscale Mission

As experts in pharmaceutical services, MMS is well-poised to now include the latest technology with IT expertise from Sage IT.

Key Points: 
  • As experts in pharmaceutical services, MMS is well-poised to now include the latest technology with IT expertise from Sage IT.
  • Intelligent automation and bot development through this relationship will allow clinical trial sponsor teams to be more productive; shifting their focus to decision making versus the processing steps involved in data collection, analysis, and reporting, said Kelly J. Hill, Executive Director, Global Project & Account Management, MMS Holdings.
  • Our goal is to make human and machine interaction smart through cognitive automation, and together MMS and Sage IT are accomplishing that.
  • Last month, MMS released Automatiqc as a configurable tool to improve document quality and reduce the time for report development through the use of intelligent automation (IA).

NASA to Livestream South America Total Solar Eclipse

Retrieved on: 
Thursday, June 27, 2019
Physical sciences, In science, Solar eclipse of March 29, Solar eclipse, Eclipse, Magnetospheric Multiscale Mission, Natural sciences, Nature, Solar eclipse of November 19, Solar eclipse of January 16

WASHINGTON, June 27, 2019 /PRNewswire/ --NASA has partnered with the Exploratorium in San Francisco to bring live views to people across the world of a total solar eclipse, occurring Tuesday, July 2, over South America.

Key Points: 
  • WASHINGTON, June 27, 2019 /PRNewswire/ --NASA has partnered with the Exploratorium in San Francisco to bring live views to people across the world of a total solar eclipse, occurring Tuesday, July 2, over South America.
  • The eclipse will only be visible directly to observers within the path of totality, which stretches across parts of Chile and Argentina.
  • Both programs will feature updates from NASA's Parker Solar Probe and Magnetospheric Multiscale missions.
  • Studying the Sun during total solar eclipses helps scientists understand the source and behavior of solar radiation that drives space weather near Earth, which can affect the health of astronauts in space and the durability of materials used to build spacecraft.

Dr. Mike Poole Joins the Board of Scientific Advisors at Top Global CRO MMS Holdings

Retrieved on: 
Thursday, May 23, 2019
Geomagnetism, Magnetospheric Multiscale Mission

SEATTLE, May 23, 2019 /PRNewswire/ -- MMS Holdings Inc. (MMS) an award-winning, data-focused CRO announced today the addition of Dr. Mike Poole, MD, FACP to its board of scientific advisors.

Key Points: 
  • SEATTLE, May 23, 2019 /PRNewswire/ -- MMS Holdings Inc. (MMS) an award-winning, data-focused CRO announced today the addition of Dr. Mike Poole, MD, FACP to its board of scientific advisors.
  • In this advisory role, Dr. Poole will provide guidance on the design, conduct, and reporting of global phase 2-4 clinical trials, the implementation of clinical development plans, and global regulatory filings.
  • "I am proud to involve myself with such a well-respected team of advisors, colleagues, and leaders that are found at MMS," says Dr. Poole.
  • Dr. Poole joins a team of industry-leading advisors that include: